Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 13/11/2008

    Ageing stem cells loose ability to adhere to stroma

    Hartmut Geiger a biochemist and stem cell researcher at Ulm University Hospital is using genetic methods to investigate the molecular basis of the physiological ageing of haematopoietic stem cells. After having spent a period in Cincinnati Geiger is currently head of the clinical research group Molecular and cellular ageing from the mechanisms of action to clinical perspectives.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ageing-stem-cells-loose-ability-to-adhere-to-stroma
  • Article - 29/10/2008

    Cannabinoids - important for memory?

    Cannabis intoxication is certainly not the original purpose of the cannabinoid receptors in the human brain. Nowadays there are known body substances which dock to the receptor molecules of nerve cells in a similar way to cannabis. A group of researchers led by pharmacologist Prof. Dr. med. Bela Szabo at the University of Freiburg is investigating the role of this molecular system in the human brain.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cannabinoids-important-for-memory
  • Article - 24/10/2008

    The game needs to be discovered

    Prof. Dr. Michael Reth is active in the field of immunology and signalling. He is an experienced scientist who is well aware of the difficulty and the cumbersome nature of deciphering signals and signalling pathways. The Freiburg bioss excellence cluster - the Centre of Biological Signalling Studies - is Reths brainchild. Karin Bundschuh from BioRegio Freiburg spoke with the scientist who works at the Max Planck Institute of Immunobiology and the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-game-needs-to-be-discovered
  • Article - 20/10/2008

    Dangerous hide and seek game in the lungs

    A group of researchers led by Prof. Dr. Frank-Michael Müller from Heidelberg has shown that mould fungi like Aspergillus fumigatus are able to develop biofilms in the lungs and protect themselves against the bodys immune defence system and drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dangerous-hide-and-seek-game-in-the-lungs
  • Article - 05/10/2008

    DFG to fund Traumatology Clinical Research Unit

    A new Clinical Research Unit at the University of Ulm is to investigate the early inflammation response and the positive impact on the immune system in casualty injuries. The insights gained will be transferred to patients.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dfg-to-fund-traumatology-clinical-research-unit
  • Article - 05/10/2008

    Award for AIDS researcher from Ulm

    The Dr. Ernst Wiethoff Award 2008 for innovative clinical research worth 25000 euros was presented to Jan Münch from the Institute of Virology at the University Hospital of Ulm. Münch discovered a new protein that blocks the HI virus.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-for-aids-researcher-from-ulm
  • Press release - 01/10/2008

    Karin Scharffetter-Kochanek: research that gets under the skin

    Prof. Karin Scharffetter-Kochanek has recently become a member of the renowned Leopoldina Academy of Sciences. In her research the skin has become a model system that serves as the basis for a trans-organ systemic approach looking at the underlying mechanisms and the complex interactions with other organs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/karin-scharffetter-kochanek-research-that-gets-under-the-skin
  • Article - 26/09/2008

    University Hospital of Ulm combines forces

    The Comprehensive Infectious Diseases Centre at the University of Ulm was recently presented to the public. The centre is responsible for coordinating the cooperation between specialists in the diagnosis and therapy of complex infectious diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/news/university-hospital-of-ulm-combines-forces
  • Article - 22/09/2008

    Controlled suicide

    Professor Dr. Christoph Borner from the University of Freiburg and his team are investigating the molecular mechanisms of apoptosis. Their research also provides insights into the medical treatment of cells that do not want to die - cancer cells.

    https://www.gesundheitsindustrie-bw.de/en/article/news/controlled-suicide
  • Press release - 25/08/2008

    Cross-border fight against cancer

    The Lake Constance region offers a broad range of cancer therapies and is home to several institutes and companies that are dealing with cancer research. The BioLAGO biotechnology network offers them a joint platform for co-operation and exchange of information.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cross-border-fight-against-cancer
  • Article - 25/08/2008

    Rare kidney tumour leads the way to a new cancer therapy

    Renal cell carcinoma is a rare disease. In addition, the disease is difficult to treat, and the majority of pharmaceutical companies find the development of new drugs for its treatment too financially risky. Their argument: the market is too small to make up for the high development costs. The Tübingen biotech company immatics was courageous enough to do so and will now be rewarded. The immatics scientists have developed a therapy that not only…

    https://www.gesundheitsindustrie-bw.de/en/article/news/rare-kidney-tumour-leads-the-way-to-a-new-cancer-therapy
  • Press release - 27/07/2008 Picture showing leukocytes (dark spots) that have left a small vein.

    White blood cells with 'icing' work far better

    Scientists from Heidelberg Munich and Aachen have shown that the adhesion molecules required by leukocytes to adhere to vascular walls depend on sugar chains for effective immune defence reactions to occur. The results could open up new strategies for the treatment of inflammatory processes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/white-blood-cells-with-icing-work-far-better
  • Press release - 19/05/2008 import_04227_de.jpg

    Viruses caught red-handed

    Prof. Thilo Stehle biochemist at the University of Tübingen wants to capture and accurately study the moment at which a virus binds to a cell. He is hoping that further insights into this process might some time enable the development of drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/viruses-caught-red-handed
  • Article - 19/05/2008

    "Fast-track" route to a PhD degree

    The Chemical Biology graduate school at Constance University was officially opened on 7th May 2008. It was created as part of Germanys excellence initiative and has been training doctoral students since the beginning of April 2008.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/fast-track-route-to-a-phd-degree
  • Article - 13/05/2008

    Just follow your nose

    Sharks can sense a few drops of blood in water. In fact they are able to smell blood in dilutions of as little as one to 10 billion. Is it just sharks or piranhas that have such an acute sense of smell? The answer is no - all fish have a highly developed sense of smell.

    https://www.gesundheitsindustrie-bw.de/en/article/news/just-follow-your-nose
  • Article - 11/05/2008

    New strategy against cervical cancer

    The German Cancer Research Centre and the Spanish company Chimera Pharma SL have signed an exclusive licensing and cooperation agreement. The two partners will develop a therapeutic vaccine against cervical cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-strategy-against-cervical-cancer
  • Article - 28/04/2008

    Mast cells of the immune system

    Immune cells sometimes kick over the traces. This could lead to allergic reactions. At the Freiburg Max Planck Institute of Immunobiology a group of researchers led by Professor Michael Huber is investigating the mechanisms that can prevent this from happening.

    https://www.gesundheitsindustrie-bw.de/en/article/news/mast-cells-of-the-immune-system
  • Article - 21/04/2008

    Human blood system in mice

    Scientists from Mannheim Heidelberg an Freiburg working together in the cooperative research area Vascular Biology have developed a method that can be used to create a human vascular system in mice which stays functional even after several months.

    https://www.gesundheitsindustrie-bw.de/en/article/news/human-blood-system-in-mice
  • Article - 20/02/2008 Scanning electron microscope image of Caenorhabditis elegans and Pristionchus pacificus.

    Threadworms throughout time

    Threadworms are versatile research objects and are excellent models for investigating fundamental evolutionary principles. Researchers at the Max Planck Institute for Developmental Biology use the Caenorhabditis and Pristionchus threadworm genera to study the molecular mechanisms of biodiversity.

    https://www.gesundheitsindustrie-bw.de/en/article/news/threadworms-throughout-time
  • Article - 09/02/2008

    A better alternative from the perspective of embryo protection

    Karin Bundschuh of BIOPRO Baden-Württemberg asked Dr. Jens Clausen how these developments should be viewed from an ethical perspective. The bioethicist spent many years studying the status of embryos the ethics of cloning and stem cell research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-better-alternative-from-the-perspective-of-embryo-protection
  • Article - 25/01/2008

    Glycosylation pattern as potential target for intervention

    Tumours develop sophisticated strategies to escape the immune defence. One of these strategies is the modification of the cells sugar coat. Specific immune cell receptors bind to these sugars thereby preventing the tumour cell from being discovered by the immune system. Medics from the University of Tübingen are investigating the mechanisms involved and are looking for therapeutic targets.

    https://www.gesundheitsindustrie-bw.de/en/article/news/glycosylation-pattern-as-potential-target-for-intervention
  • Article - 20/12/2007

    Viruses are the major cause of myocardial diseases

    About 500000 people in Germany suffer from dilatative cardiomyopathy DCM. Viral infections are the major cause of this myocardial disease. Its molecular and cellular mechanisms are being investigated in a transregional SFB project at the University of Tübingen.

    https://www.gesundheitsindustrie-bw.de/en/article/news/viruses-are-the-major-cause-of-myocardial-diseases

Page 11 / 11

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search